TP53 and cancer: Thus, E6/E6-AP-induced degradation of p53 can be considered functionally equivalent to inactivation of p53 by mutation of the p53 gene, although the situation in HPV-positive cancers may be somewhat more complicated (for detailed discussion of this issue, see [78]).